CAN-3110 Induces Immunoactivation in Recurrent Glioblastoma

Article navigation

Research Watch| November 10 2023

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2023

American Association for Cancer Research

Cancer Discov OF1.

Abstract

The oncolytic herpes virus CAN-3110 was well tolerated and can enhance antitumor immune responses.

2023

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.